ImmunoPrecise Antibodies (IPA) announced a unification under a single corporate brand, MindWalk (HYFT), and a change of its Nasdaq ticker symbol to “HYFT”. The company stated the new identity conveys its evolution into a Bio-Native AI platform business. “The company is expanding beyond specialized wet-lab services to commercialize an intelligence-platform model, launching SaaS offerings and supporting scalable partnerships,” it stated.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IPA:
- ImmunoPrecise Antibodies to Present at Global Investment Conference
- ImmunoPrecise Advances Universal Dengue Vaccine Initiative
- ImmunoPrecise Antibodies’ Strategic Divestment and Canadian Growth Drive Buy Rating
- ImmunoPrecise Antibodies Divests Dutch Subsidiary to Focus on AI Innovation
- ImmunoPrecise Antibodies Announces Details for October 2025 Annual Meeting